Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators
- 1 August 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 3 (8) , 667-676
- https://doi.org/10.1038/nri1153
Abstract
Type II cytokine receptors consist of 1 soluble and 11 transmembrane proteins that have 20–30% amino-acid identity in their extracellular domain. The ligands have a common structure with six α-helices, organized as monomers or homodimers, and have 20–30% amino-acid identity. Receptors associate as heterodimers including common chains and a high level of complexity in cytokine–receptor interactions results from the fact that one particular cytokine can bind to two different receptor complexes, and that one particular receptor complex can bind several cytokines. Type I interferons (IFNs), IL-28 and IL-29 have important roles in antiviral responses through the activation of signal transducer and activator of transcription 2 (STAT2). Inflammatory responses are modulated by members of this family; IL-10 and IFN-γ have anti- and pro-inflammatory activities, respectively; IL-22 induces the production of acute-phase reactants and IL-20 regulates the proliferation of keratinocytes. Antitumour activities have been described for type I IFNs and IL-24 delivered by adenoviruses through an unknown mechanism, potentially independent from IL-24 receptor activation.Keywords
This publication has 86 references indexed in Scilit:
- CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent MechanismsThe Journal of Experimental Medicine, 2003
- Crystal Structure of Interleukin-19 Defines a New Subfamily of Helical CytokinesJournal of Biological Chemistry, 2003
- Shared receptor components but distinct complexes for α and β interferonsJournal of Molecular Biology, 1998
- The Th1/Th2 paradigmImmunology Today, 1997
- Cytokine receptors encoded by poxviruses: a lesson in cytokine biologyImmunology Today, 1995
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994
- Modified Immunological Status of Anti-IL-10 Treated MiceCellular Immunology, 1993
- The genome of equine herpesvirus type 2 harbors an interleukin 10 (IL10)-like geneVirus Genes, 1993
- Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1Science, 1990
- Interleukin-1 and the Pathogenesis of the Acute-Phase ResponseNew England Journal of Medicine, 1984